IUI vs IVF Cost: Multiple IUIs vs One IVF Cycle

You are doing the spreadsheet that almost every couple in this position eventually does. IUIs are cheaper per cycle, IVF has higher per-cycle success, and somewhere in the middle is the right call for you. The honest version of the math is age-dependent, diagnosis-dependent, and insurance-dependent, and the answer is not "discuss with your doctor." It is a framework with real numbers that you can run on your specific situation.

The short version. The IUI vs IVF cost question is not really about per-cycle price; it is about cost-per-live-birth, which is what your money is buying. For someone 32 with unexplained infertility, three medicated IUIs at roughly $7,500 with cumulative live birth in the 25 to 30 percent range are genuinely competitive on cost-per-baby. The comparator is one IVF cycle at roughly $20,000 with 45 to 50 percent live birth. For someone 39 with low AMH, IVF wins the math on cost-per-baby, time, and probability all at once. The FORT-T and FAST-T trials are the data the conversation is built on; the framework below is how to apply it.

IUI vs IVF cost: the headline math by demographic

I want to put the comparable numbers in one place. These are typical US ranges; your specific numbers will vary by diagnosis, AMH, partner factors, and clinic. Costs assume out-of-pocket without insurance.

Under 35, unexplained infertility: Three IUIs run roughly $7,500 with cumulative live birth around 25 to 30 percent. One IVF cycle runs roughly $20,000 with 45 to 50 percent live birth. Cost-per-live-birth: roughly $25,000 to $30,000 for the IUI ladder versus roughly $40,000 to $44,000 for a single IVF cycle. The IUI ladder wins on cost-per-baby; the IVF cycle wins on time. This is the band where the choice is genuinely a choice.

Age 35 to 37, unexplained or PCOS: Three IUIs run roughly $7,500 with cumulative live birth around 20 to 25 percent. One IVF cycle runs roughly $22,000 with 35 to 40 percent live birth. Cost-per-live-birth: roughly $30,000 to $37,500 for the IUI ladder versus roughly $55,000 to $63,000 for a single IVF cycle. IUI still wins on cost-per-baby but the margin narrows.

Age 38 to 40, any diagnosis: Three IUIs run roughly $7,500 with cumulative live birth around 10 to 15 percent. One IVF cycle runs roughly $25,000 with 25 to 30 percent live birth. Cost-per-live-birth: roughly $50,000 to $75,000 for the IUI ladder versus roughly $83,000 to $100,000 for a single IVF cycle. The crossover starts to favour IVF because IUI probabilities have fallen faster than costs. The FORT-T data formalises this in this exact age band.²

Age 41 and over with low AMH: IUI is rarely cost-effective in this band. The per-cycle live birth is so low that the cost-per-baby grows large quickly. IVF with PGT-A is the conversation, with a frank discussion of donor egg options when AMH and prior IVF results suggest the egg-yield ceiling.

Severe male-factor infertility (post-wash TMC under 5 million): ICSI is required regardless of cost; IUI is not the right tool, and the cost-per-baby on IUI in this group is effectively undefined because the denominator approaches zero.

The FAST-T and FORT-T trials: the landmark data

Two trials are the foundation of the modern conversation, and they are worth understanding because their findings are what your RE is referencing implicitly.

FAST-T (also called FASTT, Reindollar 2010, Fertility and Sterility). 503 couples with unexplained infertility were randomised to one of two ladders. The standard arm did three cycles of clomid-IUI, then three cycles of gonadotropin-IUI, then up to six cycles of IVF. The accelerated arm did three cycles of clomid-IUI then IVF, skipping the gonadotropin-IUI step. The accelerated arm reached pregnancy faster with no live-birth difference, meaning the gonadotropin-IUI step added time and cost without adding babies in this cohort.¹

FORT-T (Goldman 2014, Fertility and Sterility). A similar design in women aged 38 to 42. The accelerated arm did two cycles of clomid-IUI then IVF; the standard arm did the longer ladder. The accelerated arm reached live birth significantly faster.² In this age band, the IUI portion of the standard ladder is contributing less, and the time cost of doing it is real.

These trials are the basis of the ASRM 2020 unexplained-infertility guideline, which integrates them into a recommendation that explicitly supports accelerated IVF in older patients with unexplained infertility.⁴

A useful UK-side data point is the Bahadur 2020 BMJ Open analysis of 319,000 IVF/ICSI and 30,000 IUI cycles, which produced national-scale cost-success data for the UK system.⁷ The shape is consistent with the US data: IUI cost-per-pregnancy is competitive in younger patients with mild factors, and IVF dominates in older patients.

What "cost" actually includes

The brochure number on the clinic website is one slice of cost. The real cost has more parts.

Procedure, medication, and monitoring: The largest chunk, and the only one most calculators show.

Travel and time off work: IVF concentrates more office visits into a shorter window; IUI spreads fewer visits across more months. For someone with rigid work or distance from the clinic, the IUI pattern can be more disruptive over a year even though IVF has more visits per week.

Emotional cost: Three negative pregnancy tests across three months is a different emotional experience than one IVF cycle that produces five embryos, three of which freeze. The information density is different. The grief structure is different. I do not want to overstate this. IVF has its own emotional costs, including OHSS risk, retrieval recovery, and the uncertainty of embryo grade and PGT results. The difference is real and worth naming.

Cost of "no information": IUI tells you very little when it fails. The cycle was negative; that is all you know. IVF, even when it fails, tells you about fertilisation rate, embryo grade, blastocyst development, and (with PGT-A) genetic status. That information has real value when you are trying to understand what is happening and what to change.

Cost of time: At 38 and over, every month has a real probability cost in egg quality. The time cost is not a separate line on a spreadsheet; it is a multiplier on every cycle. This is the variable the FORT-T trial was designed to measure.²

Where IUI math wins

Five scenarios where the IUI ladder is genuinely the more cost-effective starting strategy.

• Under 35 with no other factors and ovulation confirmed on letrozole: The three-cycle ladder is competitive on cost-per-baby and the time pressure is low.
• Donor sperm in a cycling person with no female-factor infertility: Natural-cycle donor IUI can be very cost-efficient, and the per-cycle numbers in this cohort are among the highest in the literature.
• When IVF is not financially accessible and patients want to attempt treatment they can afford. The honest framing here is that 25 percent cumulative live birth on three IUIs at $7,500 is real probability for real money, and "not the optimal cost-effectiveness curve" is not the same as "not worth doing."
• When religious or personal values weigh against the embryo-creation aspects of IVF: This is a valid input to the decision, and the cost-effectiveness frame is one frame, not the only frame.
• As a diagnostic step: One or two well-monitored IUI cycles can confirm ovulation, partner-sample adequacy, and timing precision before committing to IVF.

Where IVF math wins

Six scenarios where IVF dominates the math even before counting time and information value.

• Age 38 and over regardless of diagnosis. The FORT-T data is the citation.²
• Bilateral tubal disease or absent tubes: IUI cannot work; IVF is not optional.
• Severe male-factor infertility with post-wash total motile count under 5 million. ICSI through IVF is the indicated tool.
• Stage III or IV endometriosis with anatomical distortion.
• After three failed IUI cycles with confirmed ovulation and adequate partner sample. The cumulative IUI probability has been spent; cycle four is not a meaningfully different probability.
• Need for PGT: Genetic carrier status, balanced translocation, recurrent loss with euploidy questions, or advanced age with concern for aneuploidy. Only IVF embryos can be tested.
• Time-limited fertility windows: Cancer with planned chemotherapy, planned ovary-affecting surgery, autoimmune disease with anticipated immunosuppression.

Insurance changes the answer

The cost-effectiveness math collapses when insurance covers IVF. Three notes for US readers.

State mandates: Some US states (Massachusetts, Illinois, New Jersey, New York, several others) have IVF mandates that meaningfully reduce out-of-pocket IVF cost. The mandate details vary by state and by plan. If your employer's plan is fully-insured and headquartered in a mandate state, the coverage may apply. If your plan is self-funded, it may not. The HR team is the right place to ask.

Employer benefits: Carrot, Progyny, Maven, and Kindbody are the most common third-party administrators for fertility benefits. These benefits typically cover IVF more generously than IUI, often with a cycle cap or a dollar cap. The cycle cap matters because the math of "three IUIs vs one IVF" can become "three covered IUIs vs one covered IVF cycle of three," which is a different decision.

HSA/FSA: Both IUI and IVF are eligible expenses. This is small compared with state mandates and employer benefits but real.

For UK readers, NHS coverage varies by Integrated Care Board, and NICE NG156 sets the national framework.⁴ Private IUI in the UK typically runs £700 to £1,600 per cycle and private IVF £3,500 to £6,000 per cycle. The UK math is generally more favourable to IVF on cost-per-baby than the US math because the IVF price differential is smaller. Bahadur 2020 has the population-scale numbers.⁷

For the deeper IUI cost breakdown, see iui-cost-per-cycle.

The non-financial trade-offs

A few comparisons that do not show on a cost spreadsheet but matter on the decision.

Treatment intensity: IVF stim is physically more demanding. Daily subcutaneous injections for 8 to 14 days. Bloodwork and ultrasound every two to three days. Anaesthesia for retrieval. Recovery of one to three days. None of this is catastrophic, and most patients tolerate it far better than the anticipation suggests, but it is a different experience from a letrozole pill and an office visit.

Recovery: IVF retrieval needs a recovery day or two. IUI is a normal day.

Multiple-pregnancy risk: Modern IVF with elective single-embryo transfer has dramatically lowered the IVF twin rate to roughly 1 to 2 percent. Medicated-IUI twin risk is 6 to 10 percent with letrozole or clomid. This is a counterintuitive comparison (IVF is now lower-multiples than IUI in most modern practice), and it is worth knowing.

Embryo banking: IVF can produce multiple embryos in one retrieval cycle, with the option to freeze remaining embryos for future sibling cycles. IUI is one-shot per cycle. For couples wanting more than one child, this changes the long-run cost-per-completed-family math meaningfully.

A practical six-step framework

How I walk patients through the decision in clinic.

1. Confirm your diagnosis and that your AMH, antral follicle count, partner semen analysis, and HSG (if indicated) are recent (within the last 12 months).
2. Get a per-cycle live-birth estimate from your RE for both IUI and IVF given your specific data. This is more useful than any online calculator.
3. Cost the cycles realistically with your insurance and any employer benefit. Use the financial counsellor at the clinic, not the website.
4. Cost the time: Four months of IUI versus two months of IVF, and what that costs you in age and in life logistics.
5. Cost the emotional and relational load: Be honest about what each path asks of you and your partner. The path you cannot sustain is not the right path even when the math favours it.
6. Decide with your partner, not from a forum.

Questions to ask the RE

A condensed list for the consult.

1. What is my predicted per-cycle live birth on letrozole-IUI versus IVF given my age and diagnosis?
2. What is the cost-per-live-birth ratio for IUI versus IVF in your clinic for someone with my profile?
3. What insurance benefit applies to each path, and is there a financial counsellor I can speak with this week?
4. Are there clinic packages, refund programmes, or shared-risk programmes for IVF?
5. What stops being a reasonable cycle of IUI for someone in my situation? In other words, what is the off-ramp?

What you can do this week

Two practical pieces.

If you have not yet had the financial-counsellor conversation, schedule it before you commit to the next cycle. The cost framework matters as much as the clinical framework, and the clinic's financial counsellor will know which IVF refund or shared-risk programmes apply to you. The information is free; the cost of not having it is not.

Decide your time horizon with your partner before the next consult. "We will do three IUIs and then reassess" is a different decision frame from "we will do IUIs until we are pregnant or until we cannot afford another." Either is valid, but the second is the sunk-cost trap dressed up as commitment. The first lets you make the next decision from a clean slate. The IUI vs IVF cost answer is rarely a single number; it is a defined plan with a stopping rule built in.

What's next

• For the broader decision pillar: natural-vs-iui-vs-ivf-decision
• For the explicit transition decision: when-to-skip-iui-go-ivf
• For the IUI cost breakdown: iui-cost-per-cycle
• If three IUIs have failed: third-iui-failed-what-now
• For the IVF cost comparator: ivf-cost-breakdown
• For IVF success rates by age: ivf-success-rates-by-age

Sources

1. Reindollar RH, Regan MM, Neumann PJ, et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the Fast Track and Standard Treatment (FASTT) trial. Fertility and Sterility 2010;94(3):888-899. Link
2. Goldman MB, Thornton KL, Ryley D, et al. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertility and Sterility 2014;101(6):1574-1581.e2. Link
3. Diamond MP, Legro RS, Coutifaris C, et al. Letrozole, gonadotropin, or clomiphene for unexplained infertility (AMIGOS). New England Journal of Medicine 2015;373(13):1230-1240. Link
4. Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertility and Sterility 2020;113(2):305-322. Link
5. Society for Assisted Reproductive Technology (SART). National Summary Report. SART CORS. Link
6. Human Fertilisation and Embryology Authority (HFEA). Fertility treatment 2021: preliminary trends and figures. HFEA, 2023. Link
7. Bahadur G, Homburg R, Bosmans JE, et al. Observational retrospective study of UK national success, risks and costs for 319,105 IVF/ICSI and 30,669 IUI treatment cycles. BMJ Open 2020;10(3):e034566. Link